Author

Sophia Abraham

Observed names: Abraham, Sophia, S ABRAHAM

Observed institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research

OpenAlex ID: A5111889867

United States Food and Drug Administration Drug Approval Summary

2004 · Martin H. Cohen, Grant A. Williams, et al. · Clinical Cancer Research · 503

Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma

2007 · Vicki L. Goodman, Edwin P. Rock, et al. · Clinical Cancer Research · 501

PDF

Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes

2005 · Edvardas Kaminskas, Ann Farrell, et al. · Clinical Cancer Research · 423

New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process

2008 · Shiew‐Mei Huang, John M. Strong, et al. · The Journal of Clinical Pharmacology · 396

Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma

2004 · Peter F. Bross, Robert Kane, et al. · Clinical Cancer Research · 343

PDF

Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma

2007 · Bhupinder S. Mann, John R. Johnson, et al. · Clinical Cancer Research · 262

Approval Summary: Nelarabine for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma

2006 · Martin H. Cohen, John R. Johnson, et al. · Clinical Cancer Research · 89

Approval Summary

2004 · Ramzi Dagher, Ning Li, et al. · Clinical Cancer Research · 88

Topotecan in combination with cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer.

2006 · Michael Brave, Ramzi Dagher, et al. · PubMed · 40

The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters

2010 · Lokesh Jain, Sophia Abraham, et al. · Anti-Cancer Agents in Medicinal Chemistry · 4

PI-2Drug interaction studies -- study design, data analysis, and implications for dosing and labeling: Current opinion

2006 · S HUANG, K REYNOLDS, et al. · Clinical Pharmacology & Therapeutics · 3

Silent Updates: Measuring and Closing the Post-Deployment Disclosure Gap

2026 · Sophia Abraham, Ben Bucknall · Proceedings of the AAAI/ACM Conference on AI Ethics and Society

PDF

AI Incident Monitoring through a Public Health Lens

2026 · Abraham, Sophia, Chen, Taiye, et al. · arXiv (Cornell University)

PDF

Pharmacogenetics, personalized medicine and your practice

2018 · M. L. Adams, Sophia Abraham

Pharmacogenetics and Drug Metabolism

2015 · Sophia Abraham, M. L. Adams

Pharmacology and medicinal chemistry of endocrine and related drugs

2013 · M. L. Adams, Sophia Abraham

Principles of pharmacology and medicinal chemistry

2013 · Sophia Abraham, M. L. Adams

Pharmacology and medicinal chemistry of drugs affecting the nervous system

2013 · Sophia Abraham, M. L. Adams

Pharmacology and medicinal chemistry of cardiovascular and diuretic drugs

2013 · Sophia Abraham, M. L. Adams

Drug metabolism, prodrugs, and pharmacogenetics

2013 · M. L. Adams, Sophia Abraham

Pharmacology and medicinal chemistry of nonsteroidal anti-inflammatory drugs and antihistamines

2013 · M. L. Adams, Sophia Abraham

Report from the FDA Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma

2004 · Peter Bross, Robert C. Kane, et al.

Report from the FDA Approval Summary: Docetaxel in Combination with Prednisone for the Treatment of Androgen-Independent Hormone-Refractory Prostate Cancer

2004 · Ramzi Dagher, Ning Li, et al.

Works count: 23

Citation count: 2,652

H-index: 9

I10-index: 9